Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriers

Conclusions: The uptake of HT after oophorectomy in women with a BRCA1 or BRCA2 mutation varies by age, education, and surgical history. Clinician and patient awareness may lead to better utilization of HT in women who undergo oophorectomy at an early age to help mitigate the adverse effects associated with surgical menopause.
Source: Menopause - Category: OBGYN Tags: Original Studies Source Type: research